A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current ...
FILE - Food and Drug Administration (FDA) building is shown in Silver Spring, Md., Dec. 10, 2020. (AP Photo/Manuel Balce Ceneta, File) (Manuel Balce Ceneta, Copyright ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.